Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma — Stella

Recruiting

Back to Adult Gliomas, Mixed trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

University of California, San Francisco, San Francisco, California

Key details

Phase

Very early testing

Sponsor

Robert Bok, MD, PhD

Collaborators

National Cancer Institute (NCI)

Enrollment target

~40 participants

Started

April 2023

Primary completion

April 2027

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov